Actual Medicinal Product (AMP) - Epclusa 400mg/100mg tablets (Gilead Sciences Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Epclusa 400mg/100mg tablets | Start Date 27-10-2016 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 05030302 | Start Date 23-05-2017 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 33616311000001102 | 27-10-2016 |
Parent Products
-
VTMSofosbuvir + Velpatasvir
-
VMPSofosbuvir 400mg / Velpatasvir 100mg tablets
-
AMP(Current) Epclusa 400mg/100mg tablets (G...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet | 1299333 |